{"id":"W3113178943","doi":"10.1016/j.jacc.2020.11.010","title":"Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019","year":2020,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":11066,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke; National Heart, Lung, and Blood Institute; Medical Research Council; Regeneron Pharmaceuticals; Mylan; National Institutes of Health; Esperion Therapeutics; Fundação de Amparo à Pesquisa do Estado de Minas Gerais; National Human Genome Research Institute; Department for International Development; Daiichi-Sankyo; Virginia Marine Resources Commission; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Fondazione Cariplo; Amgen; National Research Foundation; Amryt Pharma; Ionis Pharmaceuticals; Department for International Development, UK Government; National Institute of Diabetes and Digestive and Kidney Diseases; Sanofi; National Kidney Foundation; Kowa Company; Eli Lilly and Company; AstraZeneca; Bill and Melinda Gates Foundation; American Heart Association","keywords":"Medicine; Burden of disease; Population; Disease burden; Years of potential life lost; Demography; Environmental health; Incidence (geometry); Disability-adjusted life year; Global health; Cause of death; Case fatality rate; Life expectancy; Public health; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}